These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34882670)

  • 1. Experimental human hookworm infection: a narrative historical review.
    Chapman PR; Giacomin P; Loukas A; McCarthy JS
    PLoS Negl Trop Dis; 2021 Dec; 15(12):e0009908. PubMed ID: 34882670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of hookworm disease: stealth, virulence, and vaccines.
    Pearson MS; Tribolet L; Cantacessi C; Periago MV; Valero MA; Jariwala AR; Hotez P; Diemert D; Loukas A; Bethony J
    J Allergy Clin Immunol; 2012 Jul; 130(1):13-21. PubMed ID: 22742835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The production of Necator americanus larvae for use in experimental human infection.
    Chapman PR; Llewellyn S; Jennings H; Becker L; Giacomin P; McDougall R; Robson J; Loukas A; McCarthy J
    Parasit Vectors; 2022 Jul; 15(1):242. PubMed ID: 35804460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterising the mucosal and systemic immune responses to experimental human hookworm infection.
    Gaze S; McSorley HJ; Daveson J; Jones D; Bethony JM; Oliveira LM; Speare R; McCarthy JS; Engwerda CR; Croese J; Loukas A
    PLoS Pathog; 2012 Feb; 8(2):e1002520. PubMed ID: 22346753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hookworm infection: Toward development of safe and effective peptide vaccines.
    Shalash AO; Hussein WM; Skwarczynski M; Toth I
    J Allergy Clin Immunol; 2021 Dec; 148(6):1394-1419.e6. PubMed ID: 34872650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hookworm infections in human and laboratory animals--differences and similarities in immune responses.
    Długosz E
    Wiad Parazytol; 2005; 51(3):219-25. PubMed ID: 16913526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathology and modulation induced by hookworms: From understanding to intervention.
    Mourão Dias Magalhães L; Silva Araújo Passos L; Toshio Fujiwara R; Lacerda Bueno L
    Parasite Immunol; 2021 Feb; 43(2):e12798. PubMed ID: 33012113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Search for protective antigens of hookworms].
    Wiśniewski M; Długosz E; Baska P; Wedrychowicz H
    Wiad Parazytol; 2006; 52(4):271-6. PubMed ID: 17432617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human hookworm infection in the 21st century.
    Brooker S; Bethony J; Hotez PJ
    Adv Parasitol; 2004; 58():197-288. PubMed ID: 15603764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults.
    Diemert DJ; Freire J; Valente V; Fraga CG; Talles F; Grahek S; Campbell D; Jariwala A; Periago MV; Enk M; Gazzinelli MF; Bottazzi ME; Hamilton R; Brelsford J; Yakovleva A; Li G; Peng J; Correa-Oliveira R; Hotez P; Bethony J
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005574. PubMed ID: 28464026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals.
    Bethony J; Loukas A; Smout M; Brooker S; Mendez S; Plieskatt J; Goud G; Bottazzi ME; Zhan B; Wang Y; Williamson A; Lustigman S; Correa-Oliveira R; Xiao S; Hotez PJ
    FASEB J; 2005 Oct; 19(12):1743-5. PubMed ID: 16037096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-five-year research progress in hookworm excretory/secretory products.
    Abuzeid AMI; Zhou X; Huang Y; Li G
    Parasit Vectors; 2020 Mar; 13(1):136. PubMed ID: 32171305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental approaches to the development of a recombinant hookworm vaccine.
    Hotez PJ; Ghosh K; Hawdon JM; Narasimhan S; Jones B; Shuhua X; Sen L; Bin Z; Haechou X; Hainan R; Heng W; Koski RA
    Immunol Rev; 1999 Oct; 171():163-71. PubMed ID: 10582170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunology of human hookworm infections.
    McSorley HJ; Loukas A
    Parasite Immunol; 2010 Aug; 32(8):549-59. PubMed ID: 20626810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the air pouch model to investigate immune responses to a hookworm vaccine containing the Na-ASP-2 protein in rats.
    Mendez S; D' Samuel A; Antoine AD; Ahn S; Hotez P
    Parasite Immunol; 2008 Jan; 30(1):53-6. PubMed ID: 18086017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hookworm excretory/secretory products modulate immune responses to heterologous and species-specific antigens.
    Diliani N; Dondji B
    Parasite Immunol; 2017 Oct; 39(10):. PubMed ID: 28796897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A history of hookworm vaccine development.
    Schneider B; Jariwala AR; Periago MV; Gazzinelli MF; Bose SN; Hotez PJ; Diemert DJ; Bethony JM
    Hum Vaccin; 2011 Nov; 7(11):1234-44. PubMed ID: 22064562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of treatment on IgE responses against parasite allergen-like proteins and immunity to reinfection in childhood schistosome and hookworm coinfections.
    Pinot de Moira A; Jones FM; Wilson S; Tukahebwa E; Fitzsimmons CM; Mwatha JK; Bethony JM; Kabatereine NB; Dunne DW
    Infect Immun; 2013 Jan; 81(1):23-32. PubMed ID: 23071136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to hookworms in patients with Crohn's disease: a case-control study.
    Kabeerdoss J; Pugazhendhi S; Subramanian V; Binder HJ; Ramakrishna BS
    Aliment Pharmacol Ther; 2011 Oct; 34(8):923-30. PubMed ID: 21848628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency testing for the experimental Na-GST-1 hookworm vaccine.
    Jariwala AR; Oliveira LM; Diemert DJ; Keegan B; Plieskatt JL; Periago MV; Bottazzi ME; Hotez PJ; Bethony JM
    Expert Rev Vaccines; 2010 Oct; 9(10):1219-30. PubMed ID: 20923271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.